The U.S. Patent and Trademark Office Clarifies How a Patentee Can Challenge Its Determination That an Ex Parte Reexamination Should Proceed

Download IconDownload Print IconPrint

The U.S. Patent and Trademark Office Clarifies How a Patentee Can Challenge Its Determination That an Ex Parte Reexamination Should Proceed

Publication

Related Solutions

Providing comprehensive solutions for the acquisition, enforcement and protection of IP.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

Intellectual Property Litigation

In the Notices in the Federal Register published June 25, 2010, the United States Patent and Trademark Office (USPTO) clarified the procedure by which a patentee in an ex parte reexamination proceeding may seek review on an Examiner's substantial new question of patentability (SNQ) determination before the Board of Patent Appeals and Interferences (BPAI). A copy of the Notice can be found here.

In its appeal brief to the BPAI, the patentee must include the SNQ issue together with its arguments on the merits for a rejection. However, in order to preserve the right to have the BPAI review the SNQ issue, the patentee must first request reconsideration of the SNQ question by the Examiner. Therefore, for any ex parte reexamination ordered on or after June 25 of this year, the patentee may seek a final agency decision on the SNQ issue from the BPAI only after having initially requested reconsideration from the Examiner.

Specifically, the patentee should file its request for reconsideration with the Examiner in either a patentee's optional statement on the Examiner's SNQ (to which a third party that requested reexamination, if any, can file a reply), or in a response to a non-final Office Action (presumably, a response to the first Office Action). Thereafter, the patent owner may seek review of the Examiner's determination of the SNQ question before the BPAI. In its subsequent appeal brief, the patent owner should set forth its position and arguments pertaining to the SNQ issue and point out from the record where and when it requested reconsideration from the Examiner. 

The Notice indicated that for ex parte reexaminations ordered before June 25, in regard to this issue, if the patentee presented the SNQ issue in its appeal brief to the BPAI, the panel of Administrative Law Judges will review the issue along with its review of any Examiner rejections and enter a final agency decision. Notably, while the USPTO contended that this is an important clarification of procedure in ex parte reexamination practice, it is not "widespread" and cited the fact that only three appeals containing a request for reconsideration of the Examiner's SNQ determination were filed in FY 2008, one in FY 2009, and only one to date in FY 2010.

Importantly, this procedure does not apply to inter partes reexamination proceedings. A determination by the USPTO in an inter partes reexamination, either that no SNQ has been raised or that a reference raises a SNQ, is final and non-appealable.

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel